Get started
SARTORIUS STEDIM BIOTECHSARTORIUS STEDIM BIOTECHSARTORIUS STEDIM BIOTECH

SARTORIUS STEDIM BIOTECH

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

4DIM chart


Full chart

4DIM upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪18.08 B‬ EUR
Dividend yield (indicated)
0.37%
Price to earnings Ratio (TTM)
105.55
Basic EPS (TTM)
1.75 EUR
Net income (FY)
‪309.70 M‬ EUR
Revenue (FY)
‪2.78 B‬ EUR
Shares float
‪25.69 M‬
Beta (1Y)
1.14

Employees


Employees (FY)
‪10.66 K‬
Change (1Y)
‪−1.27 K‬ −10.66%
Revenue / Employee (1Y)
‪260.32 K‬ EUR
Net income / Employee (1Y)
‪29.05 K‬ EUR

About SARTORIUS STED BIO


Sector
Health Technology
Industry
Medical Specialties
CEO
René Fáber
Website
sartorius.com
Headquarters
Aubagne
Founded
1978
ISIN
FR0013154002
FIGI
BBG01HQ1WTK9
Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. The firm offers a broad portfolio of products that focuses on all steps in the manufacture of a biopharmaceutical, as well as in process development as prerequisite procedures. Its technologies cover inter alia, cell line technologies, cell culture media, bioreactors, and a wide range of products for separation, purification, and concentration of biological intermediates and finished products, as well as solutions for storage and transportation. It also offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. The company was founded on September 28, 1978 and is headquartered in Aubagne, France.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

4DIM news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4DIM is 185.65 EUR — it has decreased by −0.24% in the past 24 hours. Watch SARTORIUS STEDIM BIOTECH stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EUROTLX exchange SARTORIUS STEDIM BIOTECH stocks are traded under the ticker 4DIM.
4DIM stock has fallen by −3.28% compared to the previous week, the month change is a 5.96% rise, over the last year SARTORIUS STEDIM BIOTECH has showed a −23.25% decrease.
We've gathered analysts' opinions on SARTORIUS STEDIM BIOTECH future price: according to them, 4DIM price has a max estimate of 310.00 EUR and a min estimate of 172.00 EUR. Watch 4DIM chart and read a more detailed SARTORIUS STEDIM BIOTECH stock forecast: see what analysts think of SARTORIUS STEDIM BIOTECH and suggest that you do with its stocks.
4DIM reached its all-time high on Nov 30, 2021 with the price of 526.20 EUR, and its all-time low was 146.00 EUR and was reached on Jul 19, 2024. View more price dynamics on 4DIM chart.
See other stocks reaching their highest and lowest prices.
4DIM stock is 0.24% volatile and has beta coefficient of 1.14. Track SARTORIUS STEDIM BIOTECH stock price on the chart and check out the list of the most volatile stocks — is SARTORIUS STEDIM BIOTECH there?
Today SARTORIUS STEDIM BIOTECH has the market capitalization of ‪18.08 B‬, it has decreased by −3.37% over the last week.
Yes, you can track SARTORIUS STEDIM BIOTECH financials in yearly and quarterly reports right on TradingView.
SARTORIUS STEDIM BIOTECH is going to release the next earnings report on Jan 23, 2025. Keep track of upcoming events with our Earnings Calendar.
4DIM earnings for the last quarter are 0.76 EUR per share, whereas the estimation was 0.80 EUR resulting in a −4.68% surprise. The estimated earnings for the next quarter are 0.96 EUR per share. See more details about SARTORIUS STEDIM BIOTECH earnings.
SARTORIUS STEDIM BIOTECH revenue for the last quarter amounts to ‪655.40 M‬ EUR, despite the estimated figure of ‪685.76 M‬ EUR. In the next quarter, revenue is expected to reach ‪710.61 M‬ EUR.
4DIM net income for the last quarter is ‪25.50 M‬ EUR, while the quarter before that showed ‪47.60 M‬ EUR of net income which accounts for −46.43% change. Track more SARTORIUS STEDIM BIOTECH financial stats to get the full picture.
Yes, 4DIM dividends are paid annually. The last dividend per share was 0.69 EUR. As of today, Dividend Yield (TTM)% is 0.37%. Tracking SARTORIUS STEDIM BIOTECH dividends might help you take more informed decisions.
SARTORIUS STEDIM BIOTECH dividend yield was 0.29% in 2023, and payout ratio reached 20.53%. The year before the numbers were 0.48% and 15.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has ‪10.66 K‬ employees. See our rating of the largest employees — is SARTORIUS STEDIM BIOTECH on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SARTORIUS STEDIM BIOTECH EBITDA is ‪637.60 M‬ EUR, and current EBITDA margin is 26.02%. See more stats in SARTORIUS STEDIM BIOTECH financial statements.
Like other stocks, 4DIM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SARTORIUS STEDIM BIOTECH stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SARTORIUS STEDIM BIOTECH technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SARTORIUS STEDIM BIOTECH stock shows the sell signal. See more of SARTORIUS STEDIM BIOTECH technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.